HYALACE
3.2% 32mg (H-HA) + 32mg (I-HA)/2mL HA sodium salt, 2 mL pre-filled syringe
Description
Hyalace is a hybrid hyaluronic acid bio-revitaliser formulated with 32 mg H-HA and 32 mg L-HA per 2 mL at 3.2% total HA concentration without BDDE cross-linker, delivering a combined dual-molecular-weight remodelling effect. The coexistence of high- and low-MW fractions within a single formulation provides simultaneous deep hydration depot and fibroblast stimulation, improving skin laxity, hydration, and overall surface quality over a structured course. Supplied as a sterile pre-filled syringe ready for clinical administration.
Indication
Suitable for professional bio-revitalization procedures intended for trained practitioners performing skin-quality and hydration treatments.
Packaging
Supplied as a 2 mL sterile pre-filled syringe of HA sodium salt (3.2%), one syringe per pack.
Protocol
Administer via BAP technique using a 25–27G needle: deposit 0.2 mL subcutaneously at five points per hemi-face or adapted neck/décolletage grid. Aspirate before each bolus. Recommended course: 2 injections 4 weeks apart; a follow-up session at 3–6 months maintains results. Nappage delivery at 2–4 mm intradermal depth is an alternative for diffuse hydration enhancement.
Related Products
#67
BELLONA AQUA
3 mL x 3 Syr
#83
REGENOVUE AQUASHINE PLUS GOLD
15 mg/mL Crosslinked HA (15%), 3 mL x 3ea = 9 mL
#84
REGENOVUE AQUASHINE SILVER
15 mg/mL Non-Crosslinked HA (15%), 3 mL x 3ea = 9 mL
#85
CELOSOME AQUA
2.5 mL x 5 syringes/1 pack, sodium hyaluronate, 60 mg/2.5 mL x 1 syringe